Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: September 26, 2026 at 6:08 AM UTC
| NCT Number | NCT07336472 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 360 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Fortvita Biologics (USA)Inc. |
| Last Updated on CT.gov | September 25, 2026 (Yesterday) |
As of September 26, 2026: Clinical trial NCT07336472 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 6 locations across the United States. The study is sponsored by Fortvita Biologics (USA)Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07336472 is actively recruiting participants as of September 26, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07336472 was last updated Yesterday (September 25, 2026). HelloStudys verifies this status automatically.